A Novel Human Relaxin Receptor Agonist, ML290, Attenuates Atherosclerosis- and Chronic Kidney Disease-Induced Vascular Calcification in Mice Conference

Ng, Hooi Hooi, Medina, Daniela, Agoulnik, Alexander I et al. (2020). A Novel Human Relaxin Receptor Agonist, ML290, Attenuates Atherosclerosis- and Chronic Kidney Disease-Induced Vascular Calcification in Mice . CIRCULATION, 142

cited authors

  • Ng, Hooi Hooi; Medina, Daniela; Agoulnik, Alexander I; Hutcheson, Joshua

authors

publication date

  • November 17, 2020

published in

keywords

  • Cardiac & Cardiovascular Systems
  • Cardiovascular System & Cardiology
  • Life Sciences & Biomedicine
  • Peripheral Vascular Disease
  • Science & Technology

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

volume

  • 142